Navigation Links
Exelixis Commences Public Offering of Common Stock
Date:9/10/2007

tends" and similar expressions are intended to identify forward- looking statements. These forward-looking statements are based upon Exelixis' current expectations. Forward-looking statements involve risks and uncertainties. Exelixis' actual results and the timing of events could differ materially from those anticipated in such forward-looking statements as a result of these risks and uncertainties, which include, without limitation, risks and uncertainties related to satisfaction of customary closing conditions related to the public offering. There can be no assurance that Exelixis will complete the offering of the common stock on the anticipated terms, or at all. In addition, Exelixis' business is subject to the risks detailed in Exelixis' filings with the Securities and Exchange Commission. Exelixis expressly disclaims any obligation or undertaking to release publicly any updates or revisions to any forward-looking statements contained herein to reflect any change in the company's expectations with regard thereto or any change in events, conditions or circumstances on which any such statements are based.

Exelixis and the Exelixis logo are registered U.S. trademarks.


'/>"/>
SOURCE Exelixis, Inc.
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related medicine news :

1. Pfizer Commences Its Advertising for Celebrex with All the Warnings
2. Natco Pharma Commences Production At Dehradun Unit
3. Chinas First Gay Health Clinic Commences Operations
4. Mental Health - NHS Trust Commences Specialist Transition Service
5. Surface Logix Commences Phase 2a Clinical Trial of SLx-2101 in Raynauds Disease
6. Trial of VivaGel in Sexually Active Young Women Commences
7. Controversial deal on public access of the human genome map
8. Defibrillators In Public Places Will Help Cardiac Patients
9. WHO To Support Public Health Threats
10. Public Defibrillators Found To Improve Survival Rate
11. FDA Issues Public Health Advisory on Tysabri, a New Drug for MS
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/5/2008)...s the Latest Developments in Molecular,Testing and... /PRNewswire-USNewswire/ -- The practice of,pathol...g and the promise,of personalized medicine will ch...and other imaging technologies will change the way...ogists is taking a leadership role in,making sure ...
(Date:9/5/2008)...RNewswire-USNewswire/ -- The Health Resources,and ... million in grants to,increase and improve medical... grants continue President Bush,s historic expansi...w reach more economically,vulnerable and geographi...dministrator Elizabeth M. Duke said. "In 2007, mor...
(Date:9/5/2008)...tical ,anti-cloak, could bring objects out of hidi...-- Just in case someone develops a cloak of invisi... how to uncloak the objects it hides. , Accordi...in materials underneath an invisibility cloak woul...esearchers at Shanghai Jiao Tong University in Chi...
(Date:9/5/2008)...ain to commit to develop a National AIDS,Strategy ...p. 5 /PRNewswire-USNewswire/ -- The,Republican Nat...ion of the,domestic AIDS epidemic in the United St...erseas. Neither Presidential nominee Sen. John McC... mentioned AIDS in their remarks,to Convention del...
Breaking Medicine News(10 mins):Health News:Leaders in Pathology Meet in San Diego: Sept. 25 - 28, 2008 2Health News:HRSA Announces $39 Million in Grants to Expand, Improve Health Center Services 2Health News:Domestic AIDS Epidemic Ignored at Republican National Convention 2Health News:Domestic AIDS Epidemic Ignored at Republican National Convention 3
...Dengue', State's war against mosquitoes has been f...ekhara Reddy on Friday formally from the Jali Hanu...tuency here. // The operation will also include a...e dustbin system of garbage collection in Hyderaba...
...o have persistent fluid in the middle ear, a condi...ikely to be harmed than helped by antihistamines a...d.// The drugs are no better than placebo in alle...ons of OME and expose children to a significant ri...
...inia University professor and two alumni have trac...a tumor that develops in the eye and often leads t...dings could someday lead to improved treatment for...th, professor of genetics and developmental biolog...
...ernment of Australia came under the glaring critic...rt in its allocation of funds for various health p...y pointed fingers at the current government for la...s spanning a spectrum of avenues that ranges from ...
Other Medicine News:Health News:YSR launches 'Operation Dengue' 2Health News:Allergy Drugs More Harmful Than Helpful for Chronic Ear Inflammation 2Health News:Allergy Drugs More Harmful Than Helpful for Chronic Ear Inflammation 3Health News:Team Tracks Genetic Origins of Eye Cancer 2Health News:Federal government blamed for allocating meager portion to health sector:ALP 2
(Date:9/4/2008)...RNewswire/ -- Southern Research Institute,today an...H) has selected,the organization to participate in...tion Center Network (MLPCN). The MLPCN -- a collab...ar Libraries Program which is,designed to benefit ...human,genome and validate future targets for drug ...
(Date:9/4/2008)...a for Ipilimumab to be Presented, PRINCETON, N.J....(Nasdaq: MEDX ) announced today that nine clinica...i-CTLA-4 antibody, in melanoma are scheduled to be... of the European Society,for Medical Oncology (ESM...Many of the following abstracts will include updat...
(Date:9/4/2008)...Schedule with Two Abstracts Accepted for Prese...er 2008, BRIDGEWATER, N.J., Sept. 4 /PRNewswire/ ...rmaceutical company focused on the treatment of,ca...d the appointment of,Peter L. Garrambone, Jr. to t...e,s career includes more than 50 pharmaceutical,tr...
(Date:9/3/2008)...ewswire-FirstCall/ -- Simcere,Pharmaceutical Group...r of,branded generic pharmaceuticals and manufactu...du (also known as Endostar) in China,announced th..., At the request of the SFDA, Simcere initiated a...afety and therapeutic efficacy of Endu, a modified...
Breaking Medicine Technology:Southern Research Institute Wins $14.7 Million NIH Award to Participate in Molecular Libraries Probe Production Center Network 2Southern Research Institute Wins $14.7 Million NIH Award to Participate in Molecular Libraries Probe Production Center Network 3Southern Research Institute Wins $14.7 Million NIH Award to Participate in Molecular Libraries Probe Production Center Network 4Medarex Announces Presentations at the 33rd Congress of the European Society for Medical Oncology 2Medarex Announces Presentations at the 33rd Congress of the European Society for Medical Oncology 3Aegerion Pharmaceuticals, Inc. adds Peter Garrambone to Board of Directors, Secures Additional Capital for Clinical Trials 2Simcere Pharmaceutical Group Announces Interim Results of Endu Phase IV Clinical Study 2Simcere Pharmaceutical Group Announces Interim Results of Endu Phase IV Clinical Study 3CSC Wins Enterprise System Development Contract From Centers for Medicare and Medicaid Services 2862 1CSC Wins Enterprise System Development Contract From Centers for Medicare and Medicaid Services 2862 2Portamedic Launches New Examiner Training Program 2857 1Portamedic Launches New Examiner Training Program 2857 2Portamedic Launches New Examiner Training Program 2857 3CalbaTech Issues Update 3B Beginning Training for Adult Stem Cell Collections in Atlanta 1051 1CalbaTech Issues Update 3B Beginning Training for Adult Stem Cell Collections in Atlanta 1051 2CalbaTech Issues Update 3B Beginning Training for Adult Stem Cell Collections in Atlanta 1051 3CalbaTech Issues Update 3B Beginning Training for Adult Stem Cell Collections in Atlanta 1051 4Gene Based Screen Spots Cervical Cancer Earlier 2855 1Gene Based Screen Spots Cervical Cancer Earlier 2855 2
The Infinity™ ALT single liquid stable reagent is intended for the in vitro quantitative determination of ALT in serum. , Infinity™ ALT reagent patented formulation not only provides ex
... analyzer. It is designed with the customer's anal...types of clinical chemistry tests, specific protei...tests, electrolytes and other user-definable appli...uitable for specialized chemistry applications out...
Inquire
ISI offers instrument cleaning brushes in a variety of lengths, diameters and composition. The long, thin brushes are perfect for cannulas and tubing. The smallest brushes are the answer for micros.
Medicine Products: